- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Sire Bioscience
A House of Brands for the Canadian Cannabis and Hemp Market
Sire Bioscience Inc. to Launch New Products
Sire Bioscience Announces Resignation of Director
Overview
Sire Bioscience Inc. (CSE:SIRE,OTC Pink:BLLXF,FWB:BR1B) is dedicated to becoming a vertically-integrated, leading house of brands by creating a premium and customizable experience for every cannabis consumer in Canada. The company plans to do this through its flexible business model and highly-experienced management team. Sire Bioscience intends to leverage its consumer packaged goods (CPG) experience and partnerships with leaders in the industry to develop a recognizable master brand.
From the master brand, Sire Bioscience intends to develop a variety of brand extensions for edibles, infused beverages and pets, among others. Each brand extension is expected to deliver a different cannabis function or experience and offer premium-quality products that are accessible to every customer. This approach to brand development allows the company to roll out the core brand messaging more quickly, build brand equity and create a more memorable brand. Sire Bioscience has filed 15 trademarks to protect its intellectual property (IP) and proprietary formulations.
Sire Bioscience also is dedicated to building a vertically-integrated operation by either developing those capabilities in-house or by partnering with other leaders in the cannabis space. This allows the company to focus on building its house of brands and consumer loyalty.
Sire Bioscience Company Highlights
- Sire Bioscience has filed for 15 trademarks for the company’s ingredient combinations.
- The company’s cutting-edge farming operations use less water, provide more predictable outcomes and allow for maximum growth, driving profitability.
- The company owns 50 acres of land in Leamington, Ontario, an area known as the “sun parlor of Canada.”
- The property contains 14,400-square-feet of indoor grow space, 137,088-square feet of greenhouses and 1.74-million-square feet of outdoor growing space.
- Sire Bioscience has partnerships in place with InHuis Contrived Inc., 3 Sixty Secure Corp., Eurofins Scientific, Amico Corporation and AgraFlora Organics.
- A highly-experienced and versatile leadership team leads Sire Bioscience with over 25 years of marketing and CPG expertise.
- Management holds 18 percent of the company’s shares.
Interactive Chart
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.